Effect of Oral Contraceptives on Factor VIII Clotting Activity and Factor VIII Related Antigen in Known Haemophilia Carriers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Effect of Oral Contraceptives on Factor VIII Clotting Activity and Factor VIII Related Antigen in Known Haemophilia Carriers ; volume:38 ; number:02 ; year:1977
Konferenz: VIth International Congress on Thrombosis and Haemostasis; 1977-06-27
Thrombosis and haemostasis ; 38, Heft 02 (1977)

Contributor: Stableforth, Penelope
Dormandy, Katharine M.
Hardisty, Roger M.

DOI: 10.1055/s-0039-1680751

URN: urn:nbn:de:101:1-2019061208253103436038

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Stableforth, Penelope
Dormandy, Katharine M.
Hardisty, Roger M.

Other Objects (12)

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

Text

De haemophilia

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

Text

De haemophilia

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

Text

De haemophilia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Effect of Oral Contraceptives on Factor VIII Clotting Activity and Factor VIII Related Antigen in Known Haemophilia Carriers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

De haemophilia

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

De haemophilia

Identification of a novel mutation in the factor VIII gene causing severe haemophilia A

Degradation of Factor VIII-Related Protein in Factor VIII Concentrates

Factor VIII and Factor VIII Related Antigen in Normal Pregnancy

Molecular Binding Ratio of Anti-Factor VIII to Purified Factor VIII.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

Recombinant Factor VIII Concentrates

Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers

Autosomal Factor VIII Deficiency in Rabbits: Size Variations of Rabbit Factor VIII.

Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Microheterogeneity of Human Factor VIII

De haemophilia

Related objects

Reset password